Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TENAX THERAPEUTICS, INC. | 50,000 | reported | 30 Jan 2026 | tx 4+58,000 |
| GALECTIN THERAPEUTICS INC | 25,000 | reported | 19 Jun 2013 | tx 3+45,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jan 2026 | EXERCISE | TENAX THERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |
| 17 Nov 2025 | PURCHASE | TENAX THERAPEUTICS, INC. | 5,000 | 7.23 USD | |
| 17 Nov 2025 | PURCHASE | TENAX THERAPEUTICS, INC. | 1,000 | 7.35 USD | first after silence |
| 17 Nov 2025 | PURCHASE | TENAX THERAPEUTICS, INC. | 2,000 | 7.34 USD | |
| 19 Jun 2013 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 25,000 | 0.00 USD | deriv |
| 24 May 2012 | PURCHASE | GALECTIN THERAPEUTICS INC | 10,000 | 2.35 USD | |
| 23 May 2012 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 10,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 17 Nov 2025.